Publications by authors named "Michael Drosch"

Claim this Profile
A
An Overview of Peptides and Peptide Pools for Antigen-Specific Stimulation in T-Cell Assays.
Karsten Schnatbaum, Pavlo Holenya, Sebastian Pfeil, Michael Drosch, Maren Eckey

Methods Mol Biol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide microarray-based analysis of antibody responses to SARS-CoV-2 identifies unique epitopes with potential for diagnostic test development.
Pavlo Holenya, Paul Joris Lange, Ulf Reimer, Wolfram Woltersdorf, Thomas Panterodt, Michael Drosch

Eur J Immunol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of programmed death ligand (PD-L1) in different tumors. Comparison of several current available antibody clones and antibody profiling.
Svetlana Kintsler, Maria Angela Cassataro, Michael Drosch, Pavlo Holenya, Ruth Knuechel

Ann Diagn Pathol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation of circulating tumor cells from pancreatic cancer by automated filtration.
Nora Brychta, Michael Drosch, Christiane Driemel, Johannes C Fischer, Rui P Neves

Oncotarget· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CD24hi smooth muscle subpopulation is the predominant fraction in uterine fibroids.
Michael Drosch, Nicole Schmidt, Dominique Nadine Markowski, Thomas Matthias Zollner, Markus Koch

Mol Hum Reprod· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel mouse model that closely mimics human uterine leiomyomas.
Michael Drosch, Jörn Bullerdiek, Thomas M Zollner, Florian Prinz, Markus Koch

Fertil Steril· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of activity and combination strategies with the microtubule-targeting drug sagopilone in breast cancer cell lines.
Julia Eschenbrenner, Sebastian Winsel, Stefanie Hammer, Anette Sommer, Kevin Mittelstaedt, Michael Drosch

Front Oncol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.
Tobias M Gorges, Ingeborg Tinhofer, Michael Drosch, Lars Röse, Thomas M Zollner

BMC Cancer· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis